改良Macfer切口在甲状腺癌功能性颈清中的合理性及临床应用

来源 :第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 | 被引量 : 0次 | 上传用户:wkellyai_0
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  目的:探究对甲状腺癌患者应用改良Macfer切口行功能性颈清治疗的临床效果。方法:选自本院2012年1月-2015年6月收治的甲状腺癌患者54例,随机分为两组,对照组实施传统颈淋巴结清除术,观察组甲状腺乳头状癌患者施行改良Macfer切口,行规范性功能性颈清术,对比两组术后并发症。
其他文献
  Objective: KRAS mutation was a poor prognostic factor in NSCLC, the patients with KRAS-MT has shorter survival than those of KRAS-WT.So it is urgentto furth
会议
  Objective: The aim of this study is to investigate the correlation of histopathologic subtypes with epidermal growth factor receptor (EGFR) mutations and 18
会议
  Objective: To explore the risk factors of brain metastasis (BM) and the role of treatment in patients with small cell lung cancer.Method: Clinical data of 2
会议
  Objective: CMTM1_vl7 is a member of CKLFs and is highly expressed in human testis tissues and many human tumortissues and cell lines but almost undetectable
会议
  Objective: Small cell lung cancer (SCLC) includes pure SCLC and SCLC combined with other pathologies (C-SCLC).C-SCLC accounts for about 28% of all SCLCs sub
会议
  Objective: Life expectancy has continuously improved in recently years with the development of medical level.In 2012, the amount of people who was above 60
会议
  Objective: To explore the risk factors of brain metastasis (BM) and the role of tyrosine kinase inhibitors in patients with adenocarcinima of the lung.Metho
会议
  目的:脑膜癌病是指恶性肿瘤弥漫性或多灶性播散至软脑膜,为系统性癌症严重的神经系统并发症,在实体肿瘤的发病率为5%-10%。原发灶多来源于肺癌、乳腺癌及黑色素瘤。其临床表现
  目的:分析甲状腺乳头状癌滤泡亚型(Follicular variant of papillary thyroid carcinoma,FVPTC)的临床病理特点,探讨其与经典甲状腺乳头状癌(Classical papillary thyroid
  Objective: The prognostic role of thymidylate synthase (TS) in non-small cell lung cancer (NSCLC) patients treated with oral fluoropyrimidines remains contr
会议